For CRC, the typical occurrence of RSPO gene fusions in TSA might be informative in this regard, and it has been proposed that this might point towards a different, TSA-like evolutionary trajectory for RSPO-mutant tumor development, distinct from conventional CRC [55]. This evidence concerns the gene RSPO1 and colorectal carcinoma.